The financials
Novanta Inc. by the numbers
Novanta Inc. (NOVT) reported revenue of $258M in Q1 2026 (quarter ended Apr 3, 2026), up 10% from the same quarter a year earlier. That came with a gross margin of 44% and net income of $21M (8.2% of revenue). For the full year FY2025, revenue was $981M (+3.3% year on year) and net income $54M. Its largest segment in Jun 2026 was Robotics And Automation at $88M, 33% of the disclosed total, ahead of Advanced Surgery at 25%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $258M | $233M | +10% |
| Gross profit | $114M | $104M | +8.8% |
| Operating income | $28M | $32M | −15% |
| Net income | $21M | $21M | −0.5% |
| Diluted EPS | $0.51 | $0.59 | −14% |
| Operating | Revenue | Share |
|---|---|---|
| Robotics And Automation | $88M | 33% |
| Advanced Surgery | $68M | 25% |
| Precision Medicine | $62M | 23% |
| Precision Manufacturing | $48M | 18% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $265.8M (+3.1%)
Robotics And Automation grew +14% year on yearPrecision Medicine +4.9% year on year
Segment Latestquarter on quarteryear on year
- Robotics And Automation$88.4M$88.4MQoQ +5.0%year on year +14%+5.0%+14%
- Advanced Surgery$67.5M$67.5MQoQ +8.0%year on year +12%+8.0%+12%
- Precision Medicine$62.1M$62.1MQoQ -2.9%year on year +4.9%-2.9%+4.9%
- Precision Manufacturing$47.8M$47.8MQoQ +1.6%year on year +9.1%+1.6%+9.1%
Scientific & Technical Instruments
Ranks #9 of 10 by Smart Score